Skip to main content
OpenTrials
Completed

NCT Number: NCT05073445

Stress and Resilience in Anesthesia Professionals

The purpose of this study was to analyze the correlation between the resilience of anesthesia professionals and the stress measured during a simulation session.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stress, Professional Anaesthesiology Behavior Behavioral Symptoms High Fidelity Simulation Occupational Diseases Occupational Stress Resilience Stress, Psychological

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital

Grenoble, 38000, France

About this study

This trial will be carried out at the simulation center of the training institute for health professionals of the CHU Grenoble Alpes. Volunteer anesthesia professionals and students will perform a scenario simulating a pediatric laryngospasm during a surgical incision.

Each scenario will be performed by a medical and paramedical anesthesia pair and supervised by simulation trainers.

Stress and resilience measures will be taken at various times during the study. Participants will be debriefed at the end of the simulation.

The primary objective is to analyze the correlation between anesthesia professionals' resilience and measured stress.Secondary objectives are to study the association between: SDNN-measured stress and VAS-reported stress, age and SDNN-measured stress, CD RISC 10 resilience and PSS10-reported stress, CD RISC resilience and VAS-reported stress, the effect of experience on SDNN-measured stress, multiple correlation of the different secondary criteria.

secondary criteria.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • volunteer in anesthesia

Exclusion criteria

  • Rhythm disorders
  • Endocrine pathology
  • High blood pressure
  • Pregnancy or breastfeeding in progress
  • Taking anti-inflammatory or psychotropic drugs that interfere with the heart rate
  • Interruption of professional practice in anesthesia > 2 years

Treatment and study plan

SDNN measurement

Behavioral

SDNN measurement during pediatric simulation

Primary outcomes

  1. Heart rate variability

    Time frame: during the laryngospasm (during 3 minutes at 6 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  2. Resilience

    Time frame: 5 days before scenario

    Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.

Secondary outcomes

  1. Self-reported stress

    Time frame: 5 days before scenario

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

  2. Self-reported stress

    Time frame: just Before the scenario (at 0 minute )

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

  3. Self-reported stress

    Time frame: just after briefing (at 3 minutes)

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

  4. Self-reported stress

    Time frame: just after the end of scenario (at 9 minutes)

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

  5. Self-reported stress

    Time frame: just after the debriefing (at 30 minutes)

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

  6. Perceived Stress Scale

    Time frame: 5 days before scenario

    The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.

  7. Age of anesthesia professionals

    Time frame: 5 days before scenario

    Age of anesthesia professionals: (quantitative variable)

  8. Experience in anesthesia:

    Time frame: 5 days before scenario

    Experience in anesthesia: number of years since the beginning of specialized training training (quantitative variable)

  9. Pediatric experience:

    Time frame: 5 days before scenario

    Pediatric experience: qualitative variable (yes, no)

  10. Pediatric laryngospasm experience

    Time frame: 5 days before scenario

    Pediatric laryngospasm experience: qualitative variable: (yes, no)

  11. Heart rate variability

    Time frame: 5 days before scenario (during 3 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  12. Heart rate variability

    Time frame: Before the scenario (during 3 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  13. Heart rate variability

    Time frame: during briefing (during 3 minutes at 0 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  14. Heart rate variability

    Time frame: during the scenario before the laryngospasm (during 3 minutes at 3 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  15. Heart rate variability

    Time frame: during the debriefing (3 minutes at 9 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

  16. Heart rate variability

    Time frame: after the debriefing (3 minutes at 30 minutes)

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Acronym: ResiStress

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Oct 11, 2021
Registry last updated
Mar 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.